Oncology Central

Novel blood test could quickly predict breast cancer patient’s response to palbociclib

A novel blood test could predict if breast cancer patients are responding to the recently approved drug palbociclib, months earlier than current tests.

In this study researchers compared the amount of the gene

To view restricted content, please:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.